Boyantin 150mg Tablet

Introduction

Boyantin is a medication that contains the active ingredient Benfotiamine. It is available under the brand name Boyantin. This medication is primarily used to treat certain conditions related to nerve damage caused by diabetes.

Uses

Boyantin is prescribed to individuals who have been diagnosed with diabetic neuropathy. This condition occurs when high blood sugar levels damage the nerves, leading to symptoms such as pain, numbness, and tingling in the hands and feet. By taking Boyantin, patients may experience relief from these symptoms and an improvement in their overall quality of life.

Dosage and Administration

The dosage of Boyantin may vary depending on the individual’s specific condition and medical history. Follow the instructions provided by your healthcare professional or the information on the medication label. Typically, the recommended dosage is one tablet taken orally, usually with a meal, once a day. Swallow the tablet whole and not crush or chew it.

Mechanism of Action

Benfotiamine, the active ingredient in Boyantin, is a form of vitamin B1 (thiamine). It works by increasing the levels of thiamine in the body, which then helps in reducing the damage caused by high blood sugar levels to the nerves. This mechanism of action is thought to provide relief from the symptoms of diabetic neuropathy.

Side Effects

Common side effects can include gastrointestinal symptoms such as nausea, vomiting, and diarrhea. These side effects are usually mild and go away on their own. However, if they persist or worsen, consult your healthcare professional.

In rare cases, serious side effects may occur. These can include allergic reactions, such as rash, itching, or swelling of the face, lips, or throat. If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

inform your healthcare professional about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements. Certain medications may interact with Boyantin, potentially affecting its effectiveness or increasing the risk of side effects. Common drug interactions include medications for high blood pressure, antacids, and certain antibiotics. Always consult your healthcare professional before starting or stopping any medications while taking Boyantin.

Precautions

Before starting treatment with Boyantin, inform your healthcare professional about any existing medical conditions, allergies, or sensitivities you may have. This medication may not be suitable for everyone, especially those with a known allergy to Benfotiamine or any other ingredients in the tablet.

Be cautious if you have a history of kidney disease, liver disease, or any other chronic health conditions. Your healthcare professional will assess the potential risks and benefits of using Boyantin in your specific case.

Storage

Patient Tips

• Take Boyantin as prescribed by your healthcare professional.
• maintain good blood sugar control through diet, exercise, and any other prescribed medications.
• If you experience any new or worsening symptoms while taking Boyantin, such as increased pain or numbness, inform your healthcare professional.
• Regular follow-up appointments with your healthcare professional are important to monitor your progress and make any necessary adjustments to your treatment.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Benfotiamine (International database) (Drugs.com) [Accessed 21 Jun. 2024] (online) Available at:
• Thiamin (National Institutes of Health, Office of Dietary Supplements) [Accessed 15 Jun. 2024] (online) Available at:
• Gibson GE, Luchsinger JA, Cirio R, Chen H, Franchino-Elder J, Hirsch JA, Bettendorff L, Chen Z, Flowers SA, Gerber LM, Grandville T, Schupf N, Xu H, Stern Y, Habeck C, Jordan B, Fonzetti P. Benfotiamine and Cognitive Decline in Alzheimer’s Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial. J Alzheimers Dis. 2020;78(3):989-1010. doi: 10.3233/JAD-200896. [Accessed 10 Jun. 2024] Available at:
• Tadliq Interactions Checker (Drugs.com) [Accessed 14 Jun. 2024] (online) Available at: